Sai Hanuman Sagar Boddu

Dr. Sai HS. Boddu is an Associate Professor of Pharmaceutics in the College of Pharmacy and Health Sciences, Ajman University (AU). Dr. Boddu received his Ph.D. in Pharmaceutical Sciences from the University of Missouri-Kansas City. Prior to joining AU, he worked for the University of Toledo for 7.5 years. Dr. Boddu holds 2 patents and published more than 90 research and review articles in various peer-reviewed journals. Dr. Boddu is a co-Editor of the book titled "Excipient Applications in Formulation Design and Drug Delivery". Dr. Boddu’s current research interests are developing novel drug delivery systems for treating various diseases, especially retinal diseases.

  • Ph.D. in Pharmaceutical Sciences, University of Missouri-Kansas City, USA, 2010
  • Masters in Pharmaceutics, NDMVP SAMAJ’S College Of Pharmacy, Nashik, Maharashtra, India
  • Bachelors in Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India
  • Associate Professor, Department of Pharmaceutical Sciences, Ajman University, Ajman, UAE, August, 2018 - current
  • Associate Professor, Department of Pharmacy Practice, University of Toledo, USA, August, 2016 - August, 2018
  • Assistant Professor, Department of Pharmacy Practice, University of Toledo, USA, February, 2011-August, 2016
  • Research Associate Wockhardt Research Center Chikalthana, Aurangabad, Maharashtra, India, August, 2005-August, 2006
Teaching Area
  • Pharmaceutics, Dosage forms, Pharmacokinetics
  • Biopharmaceutics
  • Clinical Pharmacokinetics
  • Drug delivery, Novel drug delivery systems, Bioanalysis, Pharmacokinetics, Nanotechnology
Conference Presentation
  • Peeters MJ, Cor MK, Boddu SHS, Nesamony J, Applying Generalizability Theory to Provide Validity Evidence for a Pharmaceutics Course Grade: Combining Exam Reliability Coefficients. 119th Annual Meeting of the American Association of Colleges of Pharmacy, Boston, Massachusetts, July 21-25, 2018
  • Sai HS. Boddu, ​Ultrasound-mediated Transdermal Delivery of Econazole Nitrate For Treating Raynaud's Phenomenon​ at the 2019 Controlled Release Society Annual Meeting & Exposition in Valencia, Spain, July 21-24, 2019
  • Boddu SHS et al., “Ultrasound-mediated Transdermal Delivery of Econazole Nitrate For Treating Raynaud's Phenomenon” at the 2019 Controlled Release Society Annual Meeting & Exposition in Valencia, Spain, July 21-24, 2019
  • Bolla PK, Boddu SHS et al., Development and In Vitro Characterization of Folate Conjugated PLGA Nanoparticles of Lutein, AAPS 2020 New Orleans in USA, Oct 26- 28, 2020
Memberships, Awards and Honors
  • University of Missouri-Kansas City, Vice Chancellor for Student Affairs and Enrollment Management Honor Recipient, Fall-2010
  • University of Missouri-Kansas City -Chancellor's Doctoral Fellowship, Fall 2008-Fall 2010
  • University of Missouri-Kansas City -Chancellor Non-Resident award, Fall, 2006-Fall,2010
  • University of Missouri-Kansas City, Best poster award for Research Day, 2010
  • AAPS-UMKC Best seminar speaker award, 2008
  • University of Missouri-Kansas City, 24th Annual Achievers of Excellence award, 2006
  • Principal Investigator, Design and Characterization of an Improved Lidocaine HCl Formulation for Dental Procedures” Research contract grant, Funded by: Neocaine, LLC, USA, AED 440760.00 (Funded), 06/2020 -06/2022
  • Principal Investigator, Taste Masking of Injectable Lidocaine HCl Formulation for Dental Procedures”, Interdisciplinary Research Grant, Funded by: Ajman University, Date: October 1st, 2019 (Funded), 10/2109-09/2020, Amount: AED 49,760
  • Principal Investigator, Development and characterization of nicotine loaded solid lipid nanoparticle hydrogels, Sponsor: Paso del Norte Health Foundation, Prime Grantee: The University of Texas at El Paso, 1/1/2018 to 2/28/2019, Amount: $11000.
  • Principal Investigator, Development and validation of an SPME-GC-MS method for determination of fluasterone in rabbit plasma, University of Texas at El Paso, Date: 7/1/18-8/31/18, Amount: $8000.
  • Principal Investigator, Development and Characterization of Tanshinone IIA Microparticles for Sustained Therapy in Age Related Macular Degeneration, University of Toledo, Date: 06/12/2017, Amount: $5000
  • Principal Investigator, In vitro release of model drugs from silicone–based elastomers and elastomer gels, Wacker Chemical Corporation, Date: 12/12/2016, Amount: $30,500
  • Principal Investigator, Solubility and Stability of Diazepam in Selected Solvent, Total care pharmacy, Date: 12/12/2016, Amount: $6,500.
  • Principal Investigator, “Electrospun Ophthalmic Inserts for Extended Delivery of Bimatoprost in Glaucoma Therapy”, deArce-Koch Memorial Endowment Fund in Support of Medical Research and Development, Date: 05/01/2015 - 05/01/2016, Amount: $10,000.
  • Principal Investigator, “To study the dermal absorption of cosmetic products across fresh human tissue samples”, L’Oréal Collaborative Project, Date of submission: 06/27/2014. Amount: $12,483
  • Principal Investigator, “Preparation and Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic acid for the Transdermal Delivery of Ketoprofen”, International Academy of Compounding Pharmacists”, Date: 02/01/2013 - 02/01/2014, Amount: $ 9,980.
  • Co-Investigator, “Waters Academic Grant Program”, Duration: 10/30/2012 - 10/29/2014
  • Co- Investigator, “Preclinical Evaluation of Photodynamic Therapy for the Treatment of Chronic Sinusitis,” The Translational Research Stimulation Award program, Principal Investigator: Reginald Baugh, MD, Professor of Surgery, Date:05/01/2012 – 05/01/2013. $25,000.00
  • Collaborating Investigator, “Novel Trans-Scleral Delivery Strategy using Bimatoprost Nanoparticles given Subconjunctivally for the Treatment of Glaucoma”, St. Luke’s Hospital Foundation, $24,600.00, 11/01/2009 – 10/31/2010